404 related articles for article (PubMed ID: 17429048)
1. Autosomal dominant polycystic kidney disease: time for a change?
Chapman AB
J Am Soc Nephrol; 2007 May; 18(5):1399-407. PubMed ID: 17429048
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic approach in autosomal dominant polycystic kidney disease.
Pei Y
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1108-14. PubMed ID: 17699332
[TBL] [Abstract][Full Text] [Related]
3. [Modern treatment of autosomal dominant polycystic kidney disease].
Wołyniec W; Jankowska MM; Rutkowski B
Pol Merkur Lekarski; 2008 Oct; 25(148):374-9. PubMed ID: 19145940
[TBL] [Abstract][Full Text] [Related]
4. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
Schrier RW
J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
[TBL] [Abstract][Full Text] [Related]
5. Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes.
Grantham JJ; Chapman AB; Torres VE
Clin J Am Soc Nephrol; 2006 Jan; 1(1):148-57. PubMed ID: 17699202
[TBL] [Abstract][Full Text] [Related]
6. Mammalian target of rapamycin and autosomal dominant polycystic kidney disease.
Wüthrich RP; Serra AL
Transplant Proc; 2009; 41(6 Suppl):S18-20. PubMed ID: 19651290
[TBL] [Abstract][Full Text] [Related]
7. [New therapies for ADPKD].
Rathaus M
G Ital Nefrol; 2007; 24(6):526-34. PubMed ID: 18278756
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of progression in autosomal dominant polycystic kidney disease.
Grantham JJ
Kidney Int Suppl; 1997 Dec; 63():S93-7. PubMed ID: 9407432
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
Torres VE; King BF; Chapman AB; Brummer ME; Bae KT; Glockner JF; Arya K; Risk D; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
Clin J Am Soc Nephrol; 2007 Jan; 2(1):112-20. PubMed ID: 17699395
[TBL] [Abstract][Full Text] [Related]
10. Optimal care of autosomal dominant polycystic kidney disease patients.
Schrier RW
Nephrology (Carlton); 2006 Apr; 11(2):124-30. PubMed ID: 16669974
[TBL] [Abstract][Full Text] [Related]
11. Earlier diagnosis of autosomal dominant polycystic kidney disease: importance of family history and implications for cardiovascular and renal complications.
Taylor M; Johnson AM; Tison M; Fain P; Schrier RW
Am J Kidney Dis; 2005 Sep; 46(3):415-23. PubMed ID: 16129202
[TBL] [Abstract][Full Text] [Related]
12. Autosomal dominant polycystic kidney disease: new treatment options and how to test their efficacy.
Wüthrich RP; Serra AL; Kistler AD
Kidney Blood Press Res; 2009; 32(5):380-7. PubMed ID: 19887826
[TBL] [Abstract][Full Text] [Related]
13. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease.
Hoevenaren IA; Wester R; Schrier RW; McFann K; Doctor RB; Drenth JP; Everson GT
Liver Int; 2008 Feb; 28(2):264-70. PubMed ID: 17927714
[TBL] [Abstract][Full Text] [Related]
14. Reliability of magnetic resonance imaging for measuring the volumetric indices in autosomal-dominant polycystic kidney disease: correlation with hypertension and renal function.
Lee YR; Lee KB
Nephron Clin Pract; 2006; 103(4):c173-80. PubMed ID: 16636585
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.
Serra AL; Poster D; Kistler AD; Krauer F; Raina S; Young J; Rentsch KM; Spanaus KS; Senn O; Kristanto P; Scheffel H; Weishaupt D; Wüthrich RP
N Engl J Med; 2010 Aug; 363(9):820-9. PubMed ID: 20581391
[TBL] [Abstract][Full Text] [Related]
16. Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease.
Gattone VH; Siqueira TM; Powell CR; Trambaugh CM; Lingeman JE; Shalhav AL
Exp Biol Med (Maywood); 2008 Aug; 233(8):952-7. PubMed ID: 18480417
[TBL] [Abstract][Full Text] [Related]
17. [Pathophysiology, epidemiology, clinical presentation, diagnosis and treatment options for autosomal dominant polycystic kidney disease].
Noël N; Rieu P
Nephrol Ther; 2015 Jul; 11(4):213-25. PubMed ID: 26113401
[TBL] [Abstract][Full Text] [Related]
18. Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease.
Lawson CR; Doulton TW; MacGregor GA
J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):139-45. PubMed ID: 17094050
[TBL] [Abstract][Full Text] [Related]
19. Cystic disease in women: clinical characteristics and medical management.
Chapman AB
Adv Ren Replace Ther; 2003 Jan; 10(1):24-30. PubMed ID: 12616460
[TBL] [Abstract][Full Text] [Related]
20. Hypertension and left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
Ecder T; Schrier RW
Expert Rev Cardiovasc Ther; 2004 May; 2(3):369-74. PubMed ID: 15151483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
